Covista Inc. (CVSA) capitalization

Current snapshot

Market Cap
$3.92B
34.0M shares × $115.25 · as of last filing 2026-03-31
Net Worth
$1.36B
Stockholders' equity · 2026-03-31
Enterprise Value
$4.51B
Market cap + debt − cash
Net Debt
$589.3M
Debt $736.3M − Cash $147.0M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-06-30 $4.88B
FY'24 2024-06-30 $2.75B
FY'23 2023-06-30 $1.57B
FY'22 2022-06-30 $1.74B
FY'21 2021-06-30 $1.84B
FY'20 2020-06-30 $1.69B
FY'19 2019-06-30 $2.67B
FY'18 2018-06-30 $3.00B
FY'17 2017-06-30 $2.43B
FY'16 2016-06-30 $1.15B
FY'15 2015-06-30 $1.96B
FY'14 2014-06-30 $2.75B
FY'13 2013-06-30 $2.00B
FY'12 2012-06-30 $2.10B
FY'11 2011-06-30 $4.18B
FY'11 2010-06-30 $3.79B
FY'11 2009-06-30

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q3'26 2026-03-31 $4.01B
Q2'26 2025-12-31 $3.75B
Q1'26 2025-09-30 $5.72B
Q4'25 2025-06-30 $4.57B
Q3'25 2025-03-31 $3.85B
Q2'25 2024-12-31 $3.49B
Q1'25 2024-09-30 $2.95B
Q4'24 2024-06-30 $2.57B
Q3'24 2024-03-31 $2.04B
Q2'24 2023-12-31 $2.40B
Q1'24 2023-09-30 $1.81B
Q4'23 2023-06-30 $1.45B
Q3'23 2023-03-31 $1.77B
Q2'23 2022-12-31 $1.64B
Q1'23 2022-09-30 $1.69B
Q4'22 2022-06-30 $1.63B
Q3'22 2022-03-31 $1.47B
Q2'22 2021-12-31 $1.49B
Q1'22 2021-09-30 $1.88B
Q4'21 2021-06-30 $1.76B
Q3'21 2021-03-31 $2.02B
Q2'21 2020-12-31 $1.78B
Q1'21 2020-09-30 $1.30B
Q4'20 2020-06-30 $1.62B
Q3'20 2020-03-31 $1.43B
Q2'20 2019-12-31 $1.90B
Q1'20 2019-09-30 $2.14B
Q4'19 2019-06-30 $2.49B
Q3'19 2019-03-31 $2.72B
Q2'19 2018-12-31 $2.84B
Q1'19 2018-09-30 $2.95B
Q4'18 2018-06-30 $2.88B
Q3'18 2018-03-31 $2.95B
Q2'18 2017-12-31 $2.61B
Q1'18 2017-09-30 $2.27B
Q4'17 2017-06-30 $2.37B
Q3'17 2017-03-31 $2.28B
Q2'17 2016-12-31 $2.00B
Q1'17 2016-09-30 $1.47B
Q4'16 2016-06-30 $1.12B
Q3'16 2016-03-31 $1.11B
Q2'16 2015-12-31 $1.64B
Q1'16 2015-09-30 $1.76B
Q4'15 2015-06-30 $1.91B
Q3'15 2015-03-31 $2.18B
Q2'15 2014-12-31 $3.11B
Q1'15 2014-09-30 $2.80B
Q4'14 2014-06-30 $2.69B
Q3'14 2014-03-31 $2.75B
Q2'14 2013-12-31 $2.30B
Q1'14 2013-09-30 $1.97B
Q4'13 2013-06-30 $1.95B
Q3'13 2013-03-31 $2.04B
Q2'13 2012-12-31 $1.53B
Q1'13 2012-09-30 $1.48B
Q4'12 2012-06-30 $2.00B
Q3'12 2012-03-31 $2.28B
Q2'12 2011-12-31 $2.62B
Q1'12 2011-09-30 $2.57B
Q4'11 2011-06-30 $4.06B
Q3'11 2011-03-31 $3.87B
Q2'11 2010-12-31 $3.40B
Q1'11 2010-09-30 $3.53B
Q4'11 2010-06-30 $3.73B
Q3'11 2010-03-31 $4.64B
Q2'11 2009-12-31 $4.03B
Q1'11 2009-09-30 $3.93B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (CVSA CIK 0000730464), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

CLDX

Celldex Therapeutics, Inc.

LLY

ELI LILLY & Co

SYRE

SPYRE THERAPEUTICS, INC.